Minimally clinically important difference in chronic breathlessness: Every little helps

American Heart Journal

Volumn 164, Issue 2, 2012, Pages 229-235

  Oxberry, Stephen G ^a   Bland, J Martin ^b   Clark, Andrew L ^c   Cleland, John G F ^c   Johnson, Miriam J ^d  

^a Kirkwood Hospice   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OXYCODONE; PLACEBO;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; EFFECT SIZE; GLOBAL IMPRESSION OF CHANGE SCALE; HEART FAILURE; HUMAN; MINIMALLY CLINICALLY IMPORTANT DIFFERENCE; MODIFIED BORG SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REGRESSION ANALYSIS; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

CHRONIC DISEASE; DYSPNEA; HEART FAILURE; HUMANS;

EID: 84864661274     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.05.003     Document Type: Article

References (37)

1. M.J. Johnson, S.G. Oxberry, and J.G. Cleland Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review Eur J Heart Fail 12 2010 137 147
2. P.S. Pang, J.G. Cleland, and J.R. Teerlink A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824 (Pubitemid 351431028)
3. I. Ekman, J.G. Cleland, and B. Andersson Exploring symptoms in chronic heart failure Eur J Heart Fail 7 2005 699 703 (Pubitemid 41125882)
4. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
5. A.H. Navigante, M.A. Castro, and L.C. Cerchietti Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated J Pain Symptom Manage 39 2010 820 830
6. T.P. Chua, D. Harrington, and P. Ponikowski Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure J Am Coll Cardiol 29 1997 147 152 (Pubitemid 27028732)
7. K.W. Wyrwich, W.M. Tierney, and F.D. Wolinsky Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life J Clin Epidemiol 52 1999 861 873 (Pubitemid 29385600)
8. J.A. Sloan Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions COPD 2 2005 57 62 (Pubitemid 40776224)
9. D.A. Mahler, and T.J. Witek Jr. The MCID of the transition dyspnea index is a total score of one unit COPD 2 2005 99 103 (Pubitemid 40776229)
10. D.S. Ander, I.P. Aisiku, and J.J. Ratcliff Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
11. D.J. Karras, M.E. Sammon, and C.A. Terregino Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334 (Pubitemid 30207971)
12. S. Dorman, C. Jolley, and A. Abernethy Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup Palliat Med 23 2009 213 227
13. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale COPD 2 2005 105 110 (Pubitemid 40776230)
14. M.J. Johnson, A.P. Abernethy, and D.C. Currow Gaps in the evidence base of opioids for refractory breathlessness. A future work plan? J Pain Symptom Manage 43 2012 614 624
15. M.B. Parshall, R.M. Schwartzstein, and L. Adams An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea Am J Respir Crit Care Med 185 2012 435 452
16. S.G. Oxberry, D.J. Torgerson, and J.M. Bland Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial Eur J Heart Fail 13 2011 1006 1012
17. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415 (Pubitemid 20025670)
18. W.R. Nugent The comparability of the standardized mean difference effect size across different measures of the same construct Educ Psychol Meas 66 2006 612 623 (Pubitemid 44060236)
19. J. Powers, and S.J. Bennett Measurement of dyspnea in patients treated with mechanical ventilation Am J Crit Care 8 1999 254 261
20. M. Herigstad, A. Hayen, and K. Wiech Dyspnoea and the brain Respir Med 105 2011 809 817
21. A. von Leupoldt, T. Sommer, and S. Kegat Down-regulation of insular cortex responses to dyspnea and pain in asthma Am J Respir Crit Care Med 180 2009 232 238
22. C. Bausewein, M. Farquhar, and S. Booth Measurement of breathlessness in advanced disease: a systematic review Respir Med 101 2007 399 410 (Pubitemid 46205909)
23. S. Dorman, A. Byrne, and A. Edwards Which measurement scales should we use to measure breathlessness in palliative care? A systematic review Palliat Med 21 2007 177 191 (Pubitemid 46958244)
24. J.P. Solano, B. Gomes, and I.J. Higginson A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease J Pain Symptom Manage 31 2006 58 69 (Pubitemid 43143299)
25. A.P. Abernethy, C.F. McDonald, and P.A. Frith Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial Lancet 376 2010 784 793
26. R. Barton, A. English, and S. Nabb A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study Lung Cancer 70 2010 313 319
27. D.C. Currow, M. Agar, and J. Smith Does palliative home oxygen improve dyspnoea? A consecutive cohort study Palliat Med 23 2009 309 316
28. G. Borg, and H. Linderholm Exercise performance and perceived exertion in patients with coronary insufficiency, arterial hypertension and vasoregulatory asthenia Acta Med Scand 187 1970 17 26
29. G. Borg A category scale with ratio properties for intermodal and interindividual comparisons H.G. Geissler, Petzholdt Psychophysical Judgements and the Process of Perception 1982 Deutscher Verlag Berlin
30. A.P. Abernethy, J.E. Herndon, and J.L. Wheeler Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data Health Serv Res 43 2008 1975 1991
31. E. Basch, A.P. Abernethy, and B.B. Reeve Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research Value Health 14 2011 965 966
32. E. Basch, and A.P. Abernethy Supporting clinical practice decisions with real-time patient-reported outcomes J Clin Oncol 29 2011 954 956
33. E.M. Basch, B.B. Reeve, and S.A. Mitchell Electronic toxicity monitoring and patient-reported outcomes Cancer J 17 2011 231 234
34. D.L. Patrick, L.B. Burke, and J.H. Powers Patient-reported outcomes to support medical product labeling claims: FDA perspective Value Health 10 Suppl. 2 2007 S125 S137
35. G.H. Guyatt, M. Townsend, and J. Keller Measuring functional status in chronic lung disease: conclusions from a randomized control trial Respir Med 83 1989 293 297
36. C.C. Preston, and A.M. Colman Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences Acta Psychol (Amst) 104 2000 1 15
37. G.H. Guyatt, D. Osoba, and A.W. Wu Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383 (Pubitemid 34260746)